标题
Designing development programs for non-traditional antibacterial agents
作者
关键词
-
出版物
Nature Communications
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-31
DOI
10.1038/s41467-019-11303-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug combinations: a strategy to extend the life of antibiotics in the 21st century
- (2019) Mike Tyers et al. NATURE REVIEWS MICROBIOLOGY
- Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?
- (2019) Itamar Megiddo et al. HEALTH ECONOMICS
- ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers
- (2019) E. Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Compensation for cures: Why we should pay a premium for participation in ‘challenge studies’
- (2019) Jonathan Anomaly et al. BIOETHICS
- Non-traditional Antibacterial Therapeutic Options and Challenges
- (2019) Ursula Theuretzbacher et al. Cell Host & Microbe
- CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial
- (2019) Pierre-François Laterre et al. LANCET INFECTIOUS DISEASES
- Are noninferiority studies ethically inferior?
- (2018) Mark A. Graber et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
- (2018) Dale N Gerding et al. CLINICAL INFECTIOUS DISEASES
- Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?
- (2018) John H Powers et al. BMJ-British Medical Journal
- Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?
- (2018) John H Powers et al. BMJ-British Medical Journal
- Engineering therapeutic antibodies to combat infectious diseases
- (2018) Ellen K Wagner et al. Current Opinion in Chemical Engineering
- Reprioritizing Research Activity for the Post-Antibiotic Era:Ethical, Legal, and Social Considerations
- (2017) Spencer Phillips Hey et al. HASTINGS CENTER REPORT
- Protection of the Human Gut Microbiome From Antibiotics
- (2017) Jean de Gunzburg et al. JOURNAL OF INFECTIOUS DISEASES
- When clinical trials compete: prioritising study recruitment
- (2017) Luke Gelinas et al. JOURNAL OF MEDICAL ETHICS
- Market watch: Innovation in the preclinical antibiotic pipeline
- (2017) Ursula Theuretzbacher et al. NATURE REVIEWS DRUG DISCOVERY
- The immunological mechanisms that control pneumococcal carriage
- (2017) Simon P. Jochems et al. PLoS Pathogens
- Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011
- (2017) Peter Doshi et al. JAMA Internal Medicine
- What Should Patients Be Told About Noninferiority Studies?
- (2017) Jerry Menikoff JAMA Internal Medicine
- Alternative pre-approved and novel therapies for the treatment of anthrax
- (2016) Breanne M. Head et al. BMC INFECTIOUS DISEASES
- Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks
- (2016) Anthony McDonnell et al. CLINICAL INFECTIOUS DISEASES
- Alternatives to antibiotics—a pipeline portfolio review
- (2016) Lloyd Czaplewski et al. LANCET INFECTIOUS DISEASES
- Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
- (2016) Gerard D. Wright TRENDS IN MICROBIOLOGY
- Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?
- (2016) Kris Huygen Virulence
- A comprehensive regulatory framework to address the unmet need for new antibacterial treatments
- (2013) John H Rex et al. LANCET INFECTIOUS DISEASES
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Equipoise: asking the right questions for clinical trial design
- (2012) Steven Joffe et al. Nature Reviews Clinical Oncology
- Biomarkers and surrogate endpoints in clinical trials
- (2012) Thomas R. Fleming et al. STATISTICS IN MEDICINE
- Equipoise and the Dilemma of Randomized Clinical Trials
- (2011) Franklin G. Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!
- (2010) Paul G. Ambrose et al. CLINICAL INFECTIOUS DISEASES
- Limits to research risks
- (2009) F G Miller et al. JOURNAL OF MEDICAL ETHICS
- Use of Pharmacokinetics and Pharmacodynamics in a Failure Analysis of Community‐Acquired Pneumonia: Implications for Future Clinical Trial Study Design
- (2008) Paul G. Ambrose CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now